PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 16, 2024Post Reproductive Health0 citations

Thai postmenopausal woman’s view in genitourinary syndrome of menopause

View Full Paper
PWPattra WongapaiTJTitima JirasawasPVPatsama Vichinsartvichai

Key Points

Key points are not available for this paper at this time.

Abstract

Objectives To determine the prevalence of genitourinary syndrome of menopause (GSM) and their awareness, attitudes, and perception of this issue. Study design Using a specifically designed questionnaire, interviews were performed on 500 Thai postmenopausal women who attended at Vajira Hospital, Bangkok, Thailand, from August 2021 to April 2022. Results The mean age of the 500 participants was 60.39 ± 8.12 years. The prevalence of GSM was 47.2%. The common symptoms affected by GSM were vaginal dryness (38.5%), urinary urgency (24.6%), dyspareunia (13.6%), vaginal irritation (10.2%), vaginal burning (7.2%), and dysuria (5.9%). One-half of the women were uncomfortable talking about GSM. Three-quarters who did not reveal GSM symptoms believed that the problem was a part of aging. Only 20.3% of women who suffer from symptoms consulted a health care provider (HCP). Of the women who had been prescribed treatment, 84.6% of these women reported better quality of life. Conclusions GSM is a meaningful decrement in quality of life. Most Thai postmenopausal women who had symptoms believed that the problem was the aging process. Awareness of GSM and available treatment would be a further benefit.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wongapai et al. (2024) studied this question.

synapsesocial.com/papers/68e69d57b6db643587622904https://doi.org/10.1177/20533691241254701
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Women's EMPOWER Survey: Identifying Women's Perceptions on Vulvar and Vaginal Atrophy and Its Treatment2017 · 215 citations
  2. 2Female Sexual Arousal Disorders2012 · 72 citations
  3. 3Treatment of postmenopausal vaginal atrophy with 10-µg estradiol vaginal tablets2012 · 22 citations
  4. 4Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women2008 · 296 citations
  5. 5Genitourinary syndrome of menopause2014 · 681 citations